PMID: 11606001Oct 19, 2001Paper

First-episode non-affective psychosis in a total urban population: a 5-year follow-up

Social Psychiatry and Psychiatric Epidemiology
B SvedbergJ Cullberg

Abstract

The aim of this study is to investigate incidence rates, treatment, and outcome of a total in- and outpatient population of 71 patients (of 18-45 years of age) treated for a first-episode psychosis (DSM-IV) in three catchment areas in Stockholm. The study is based on the investigation of records and databases and on information by staff members and patients. The incidence rate was 34.8 per 100,000 inhabitants (aged 18-45 years) and 16.5 per 100,000 inhabitants (total population). Sixty percent were diagnosed with schizophrenia syndromes. At 5-year follow-up, 73 % of the patients in the schizophrenia syndromes group versus 47% of the non-schizophrenia group had a sick pension or were on long-term sick leave. Nine percent of the schizophrenia patients and 39% of the non-schizophrenia psychosis patients were rated as not being in need of treatment. Non-compliance of medication was present in one-third of those patients prescribed neuroleptic medication. Seven percent had never received neuroleptic medication, all of whom were rated as ill at the 5-year follow-up. Incidence of treated first-episode psychosis is higher than has earlier been found, when exclusively outpatient treated individuals are also included. The social outcome ...Continue Reading

Citations

Nov 28, 2008·Social Psychiatry and Psychiatric Epidemiology·Aileen O'BrienSwaran P Singh
Sep 25, 2003·Journal of Clinical Epidemiology·Renee D Goodwin
Apr 17, 2008·Harvard Review of Psychiatry·Alice CharachRobin E Gearing
May 19, 2006·Schizophrenia Bulletin·Dawn I VelliganAlexander L Miller
Apr 12, 2014·The British Journal of Psychiatry : the Journal of Mental Science·Antonio LasalviaUNKNOWN PICOS-Veneto Group
Oct 20, 2006·Nordic Journal of Psychiatry·Ingrid LindgrenJohan Cullberg
Jan 1, 2007·International Journal of Psychiatry in Clinical Practice·Meera NarasimhanPrakash Masand
Jun 29, 2011·Psychiatry Research·Claire E RamsayMichael T Compton
Sep 6, 2003·International Journal of Mental Health Nursing·Bodil SvedbergKim Lützén
Oct 7, 2006·Acta Psychiatrica Scandinavica·G P AmmingerP D McGorry
May 29, 2016·Psychiatry Research·Anna-Karin OlssonLars Helldin
Oct 30, 2004·Scandinavian Journal of Public Health. Supplement·Gunnel Hensing, Rolf Wahlström
Jan 19, 2008·The British Journal of Psychiatry. Supplement·Paulo R MenezesRobin M Murray
May 30, 2019·Psychiatric Services : a Journal of the American Psychiatric Association·Marleen RadiganLisa Dixon
Sep 29, 2019·The International Journal of Risk & Safety in Medicine·P B Danborg, P C Gøtzsche
Sep 13, 2002·Acta Psychiatrica Scandinavica·J CullbergI-M Wieselgren
Feb 24, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Jennifer PayneBrown Nicole
Feb 10, 2020·Community Mental Health Journal·Christina WusinichPhoebe Friesen
Jul 20, 2019·Social Psychiatry and Psychiatric Epidemiology·Siobhan ReynoldsBrian O'Donoghue

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here